Sorscher EJ - Search Results

1

Rowe SM, Miller S, Sorscher EJ. Rowe SM, et al. Among authors: sorscher ej. N Engl J Med. 2005 May 12;352(19):1992-2001. doi: 10.1056/NEJMra043184. N Engl J Med. 2005. PMID: 15888700 No abstract available.

2

Recombinant synthesis, purification, and nucleotide binding characteristics of the first nucleotide binding domain of the cystic fibrosis gene product.

Hartman J, Huang Z, Rado TA, Peng S, Jilling T, Muccio DD, Sorscher EJ. Hartman J, et al. Among authors: sorscher ej. J Biol Chem. 1992 Apr 5;267(10):6455-8. J Biol Chem. 1992. PMID: 1372605 Free article.

3

Diagnosis of genetic disease by primer-specified restriction map modification, with application to cystic fibrosis and retinitis pigmentosa.

Sorscher EJ, Huang Z. Sorscher EJ, et al. Lancet. 1991 May 11;337(8750):1115-8. doi: 10.1016/0140-6736(91)92785-z. Lancet. 1991. PMID: 1674012

4

Antisense oligodeoxynucleotide to the cystic fibrosis gene inhibits anion transport in normal cultured sweat duct cells.

Sorscher EJ, Kirk KL, Weaver ML, Jilling T, Blalock JE, LeBoeuf RD. Sorscher EJ, et al. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7759-62. doi: 10.1073/pnas.88.17.7759. Proc Natl Acad Sci U S A. 1991. PMID: 1715578 Free PMC article.

5

Interaction between cystic fibrosis transmembrane conductance regulator and outwardly rectified chloride channels.

Jovov B, Ismailov II, Berdiev BK, Fuller CM, Sorscher EJ, Dedman JR, Kaetzel MA, Benos DJ. Jovov B, et al. Among authors: sorscher ej. J Biol Chem. 1995 Dec 8;270(49):29194-200. doi: 10.1074/jbc.270.49.29194. J Biol Chem. 1995. PMID: 7493947 Free article.

6

Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line.

Bedwell DM, Kaenjak A, Benos DJ, Bebok Z, Bubien JK, Hong J, Tousson A, Clancy JP, Sorscher EJ. Bedwell DM, et al. Among authors: sorscher ej. Nat Med. 1997 Nov;3(11):1280-4. doi: 10.1038/nm1197-1280. Nat Med. 1997. PMID: 9359706

7

Recombinant synthesis of cystic fibrosis transmembrane conductance regulator and functional nucleotide-binding domains.

King SA, Sorscher EJ. King SA, et al. Among authors: sorscher ej. Methods Enzymol. 1998;292:686-97. doi: 10.1016/s0076-6879(98)92053-5. Methods Enzymol. 1998. PMID: 9711592 No abstract available.

8

Cystic fibrosis transmembrane conductance regulator (CFTR) nucleotide-binding domain 1 (NBD-1) and CFTR truncated within NBD-1 target to the epithelial plasma membrane and increase anion permeability.

Clancy JP, Hong JS, Bebök Z, King SA, Demolombe S, Bedwell DM, Sorscher EJ. Clancy JP, et al. Among authors: sorscher ej. Biochemistry. 1998 Oct 27;37(43):15222-30. doi: 10.1021/bi980436f. Biochemistry. 1998. PMID: 9790686

9

The mechanism underlying cystic fibrosis transmembrane conductance regulator transport from the endoplasmic reticulum to the proteasome includes Sec61beta and a cytosolic, deglycosylated intermediary.

Bebök Z, Mazzochi C, King SA, Hong JS, Sorscher EJ. Bebök Z, et al. Among authors: sorscher ej. J Biol Chem. 1998 Nov 6;273(45):29873-8. doi: 10.1074/jbc.273.45.29873. J Biol Chem. 1998. PMID: 9792704 Free article.

10

A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis.

Ruiz FE, Clancy JP, Perricone MA, Bebok Z, Hong JS, Cheng SH, Meeker DP, Young KR, Schoumacher RA, Weatherly MR, Wing L, Morris JE, Sindel L, Rosenberg M, van Ginkel FW, McGhee JR, Kelly D, Lyrene RK, Sorscher EJ. Ruiz FE, et al. Among authors: sorscher ej. Hum Gene Ther. 2001 May 1;12(7):751-61. doi: 10.1089/104303401750148667. Hum Gene Ther. 2001. PMID: 11339892 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

205 results

Search Page